{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:53:50Z","timestamp":1788778430584,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.radonc.2024.110436","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T20:54:53Z","timestamp":1721249693000},"page":"110436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Reduced frequency and severity of radiation esophagitis without marginal failure risk by contralateral esophagus sparing IMRT in stage III non-small cell lung cancer patients undergoing definitive concurrent chemoradiotherapy"],"prefix":"10.1016","volume":"199","author":[{"given":"Hae Sol","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myoung","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongryull","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyeol","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyu","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110436_b0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2005.04.004","article-title":"Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy","volume":"62","author":"Takeda","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0360-3016(02)03937-8","article-title":"Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy","volume":"55","author":"Singh","year":"2003","journal-title":"Int J Radiation Oncol, Biol, Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/157488712799363235","article-title":"Esophagitis, treatment-related toxicity in non-small cell lung cancer","volume":"7","author":"Bar-Ad","year":"2012","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.radonc.2024.110436_b0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ijrobp.2015.03.018","article-title":"A contralateral esophagus-sparing technique to limit severe esophagitis associated with concurrent high-dose radiation and chemotherapy in patients with thoracic malignancies","volume":"92","author":"Al-Halabi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0025","doi-asserted-by":"crossref","first-page":"e20644","DOI":"10.1200\/JCO.2023.41.16_suppl.e20644","article-title":"Application of a contralateral esophageal-sparing technique to reduce radiation esophagitis in limited-stage small cell lung cancer treated with twice-daily radiotherapy and concurrent chemotherapy","volume":"41","author":"Hu","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0030","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ijrobp.2023.06.830","article-title":"Effect of contralateral esophagus sparing in hypofractionated radiotherapy for ultra-central NSCLC","volume":"117","author":"Zhu","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.5603\/RPOR.a2022.0110","article-title":"Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling","volume":"27","author":"Lazar-Poniatowska","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2024.110436_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13014-017-0771-6","article-title":"Intentional avoidance of the esophagus using intensity modulated radiation therapy to reduce dysphagia after palliative thoracic radiation","volume":"12","author":"Granton","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2015.00127","article-title":"Esophagus and contralateral lung-sparing IMRT for locally advanced lung cancer in the community hospital setting","volume":"5","author":"Kao","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0050","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, et al: The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67:93-99, 2017.","DOI":"10.3322\/caac.21388"},{"key":"10.1016\/j.radonc.2024.110436_b0055","first-page":"123","article-title":"Tolerance of normal tissue to therapeutic radiation","volume":"1","author":"Emami","year":"2013","journal-title":"Rep Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.prro.2017.07.010","article-title":"Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: results of a large statewide observational study","volume":"8","author":"Paximadis","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110436_b0070","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1158\/1078-0432.CCR-15-3101","article-title":"EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer: a retrospective analysis","volume":"22","author":"Gainor","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2024.110436_b0075","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jtho.2021.01.1628","article-title":"Durvalumab for stage III EGFR-mutated NSCLC after definitive chemoradiotherapy","volume":"16","author":"Aredo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/pme.12299","article-title":"Assessing analgesic use in patients with advanced cancer: development of a new scale\u2013the Analgesic Quantification Algorithm","volume":"15","author":"Chung","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.radonc.2024.110436_b0085","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2013.07.029","article-title":"Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis","volume":"87","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2005.03.037","article-title":"Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non\u2013small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience","volume":"63","author":"Machtay","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110436_b0100","doi-asserted-by":"crossref","first-page":"e0218627","DOI":"10.1371\/journal.pone.0218627","article-title":"Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB\/C non-small-cell lung carcinoma patients: Analysis of 956 patients","volume":"14","author":"Topkan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2024.110436_b0105","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jamaoncol.2021.0281","article-title":"Assessment of a contralateral esophagus-sparing technique in locally advanced lung cancer treated with high-dose chemoradiation: a phase 1 nonrandomized clinical trial","volume":"7","author":"Kamran","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.7664","article-title":"Palliative radiation for advanced central lung tumors with intentional avoidance of the esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial","volume":"8","author":"Louie","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13014-018-1073-3","article-title":"An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy","volume":"13","author":"Ma","year":"2018","journal-title":"Radiation Oncol"},{"key":"10.1016\/j.radonc.2024.110436_b0120","article-title":"Effect of segmental abutting esophagus-sparing technique to reduce severe esophagitis in limited-stage small-cell lung cancer patients treated with concurrent hypofractionated thoracic radiation and chemotherapy","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024007060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024007060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:48:36Z","timestamp":1729057716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024007060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"alternative-id":["S0167814024007060"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110436","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced frequency and severity of radiation esophagitis without marginal failure risk by contralateral esophagus sparing IMRT in stage III non-small cell lung cancer patients undergoing definitive concurrent chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110436"}}